US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

electroCore

us-stock
To Invest in {{usstockname}}
us-stock
$4.994 0.0526(5.26%) ECOR at 04 Dec 2025 04:30 PM Medical Devices
Lowest Today 4.81
Highest Today 4.95
Today’s Open 4.9306
Prev. Close 4.75
52 Week High 19.49
52 Week Low 4.16
Day’s Range: Low 4.81 High 4.95
52-Week Range: Low 4.16 High 19.49
1 day return -
1 Week return -4.95
1 month return -3.03
3 month return -2.83
6 month return -7.86
1 year return -58.29
3 year return -13.51
5 year return -78.87
10 year return -

Institutional Holdings

Awm Investment Company Inc 3.56

Vanguard Group Inc 3.06

Renaissance Technologies Corp 2.38

Vanguard Total Stock Mkt Idx Inv 1.86

International Assets Investment Management, LLC 1.02

Geode Capital Management, LLC 0.88

Goss Wealth Management LLC 0.82

Vanguard Institutional Extnd Mkt Idx Tr 0.82

Sontag Advisory LLC 0.63

JAFFETILCHIN INVESTMENT PARTNERS, LLC 0.55

HighTower Advisors, LLC 0.47

Fidelity Extended Market Index 0.40

BlackRock Inc 0.36

State Street Corp 0.35

Two Sigma Investments LLC 0.27

Morgan Stanley - Brokerage Accounts 0.24

Perritt Capital Management Inc. 0.20

Perritt MicroCap Opportunities Investor 0.20

Jump Financial LLC 0.18

iShares Micro-Cap ETF 0.17

Northern Trust Corp 0.15

Fidelity Nasdaq Composite Index 0.14

Extended Equity Market Fund K 0.13

TOBIAS FINANCIAL ADVISORS, INC. 0.13

UBS Group AG 0.12

Fidelity Total Market Index 0.12

Bridgeway Ultra-Small Company 0.11

Fidelity Series Total Market Index 0.10

Spartan Extended Market Index Pool F 0.10

Northern Trust Extended Eq Market Idx 0.08

NT Ext Equity Mkt Idx Fd - L 0.08

NT Ext Equity Mkt Idx Fd - NL 0.06

Bfsg, LLC 0.05

Spartan Total Market Index Pool G 0.05

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.05

Vanguard Balanced Index Inv 0.04

State St US Extended Mkt Indx NL Cl C 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Kozak & Associates, Inc. 0.01

Market Status

Strong Buy: 3

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 37.98 M

PB Ratio 34.8852

PE Ratio 0.0

Enterprise Value 38.24 M

Total Assets 20.47 M

Volume 18863

Company Financials

Annual Revenue FY23:13399000 13.4M, FY22:8592000 8.6M, FY21:5451200 5.5M, FY20:3495800 3.5M, FY19:2390000 2.4M

Annual Profit FY23:11055000 11.1M, FY22:6976000 7.0M, FY21:4066200 4.1M, FY20:1758300 1.8M, FY19:1233000 1.2M

Annual Net worth FY23:-20592000 -20.6M, FY22:-22162000 -22.2M, FY21:-17218100 -17.2M, FY20:-23511100 -23.5M, FY19:-45147000 -45.1M

Quarterly Revenue Q3/2025:8689000 8.7M, Q2/2025:7381000 7.4M, Q1/2025:6719000 6.7M, Q3/2024:6554000 6.6M, Q2/2024:6139000 6.1M

Quarterly Profit Q3/2025:7470000 7.5M, Q2/2025:6442000 6.4M, Q1/2025:5706000 5.7M, Q3/2024:5489000 5.5M, Q2/2024:5301000 5.3M

Quarterly Net worth Q3/2025:-3405000 -3.4M, Q2/2025:-3671000 -3.7M, Q1/2025:-3855000 -3.9M, Q3/2024:-2497000 -2.5M, Q2/2024:-2655000 -2.7M

Fund house & investment objective

Company Information electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an, app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Organisation Medical Devices

Employees 73

Industry Medical Devices

CEO Mr. Daniel S. Goldberger

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right